))
10 minutes of science is a new podcast series from The Royal Australian and New Zealand College of Ophthalmologists Women in Ophthalmology. Each edition features an expert in their field discussing an article of their choosing. These articles have been selected due to their impact on the real-world practice of ophthalmology. The series is aimed at the general comprehensive ophthalmologists and includes topics across a range of subspecialties. Hosted by Women in Ophthalmology Deputy Chair Dr ...
…
continue reading
Impressed with a 50% success rate? Witnessing blinding acute angle attacks motivated Dr Judy Ku’s passion for primary angle closure disease. She explores how a 50% success rate sounds impressive, but its real-world outcomes are less, especially when factoring in the economic costs of large population screening and proactive treatment. So, while las…
…
continue reading
Superiority complex? It is complex Associate Professor Susan Carden examines the RAINBOW study, which compared treatment of ROP with ranibizumab versus laser therapy. Noting the extension trial may uncover more, there might be a superior treatment method. Listen in to find out more. View article here Susan Carden is an Associate Professor in the De…
…
continue reading
1
S02E07 For Fuchs’s sake, taking out the sting. Hyperosmolar Eye Drops for Diurnal Corneal Edema in Fuchs’ Endothelial Dystrophy
9:48
For Fuchs’s sake, taking out the sting Hyperosmolar Eye Drops for Diurnal Corneal Edema in Fuchs’ Endothelial Dystrophy Professor Stephanie Watson talks taking the sting out of Hyperosmolar Eye Drops for Diurnal Corneal Edema in Fuchs’ Endothelial Dystrophy. Do the clinical outcomes support their use, and how robust was this Double-Masked, Randomiz…
…
continue reading
Talking “pulleyes”… and when they no longer hold tension When a trans-pacific collaboration results in need-to-know outcomes for the general ophthalmologist. The differences in patterns of sagging eye syndrome lead to different treatment paths. Dr Sonia Moorthy unpacks diagnosis, simple and effective management strategies and ways to reduce unneces…
…
continue reading
1
S02E05 Rebounds are not limited to basketball. Three-Year Clinical Trial of Low-Concentration Atropine for Myopia Progression (LAMP) Study: Continued Versus Washout.
9:10
Rebounds are not limited to basketball. Three-Year Clinical Trial of Low-Concentration Atropine for Myopia Progression (LAMP) Study: Continued Versus Washout. Rebounds are not limited to basketball. Dr Sarah Hull examines the rebound effect in the Three-Year Clinical Trial of Low-Concentration Atropine for Myopia Progression (LAMP) Study. What are …
…
continue reading
1
S02E04 Beyond the surface Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial
9:52
Beyond the surface. Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial A modern landmark glaucoma trial and first-of-its-kind that provides surprising and useful outcomes for current practice and research. Can the visual field be preserved with an intraocular-pressure-lowering drug in patients with open…
…
continue reading
1
S02E03 Considering it all Myopia control effect of defocus incorporated multiple segments (DIMS) spectacle lens in Chinese children: results of a 3- year follow- up study
11:58
Considering it all. Myopia control effect of defocus incorporated multiple segments (DIMS) spectacle lens in Chinese children: results of a 3- year follow-up study Dr Caroline Catt investigates myopia progression and axial elongation in children. Limitations on data impact treatment choices – what should be considered for DIMs lenses? Age, ethnicit…
…
continue reading
1
S02E02 Mucking out the stables. The Ruptured Globe, Sympathetic Ophthalmia, and the 14-Day Rule
14:02
Mucking out the stables. The Ruptured Globe, Sympathetic Ophthalmia, and the 14-Day Rule Dr Freny Kalapesi examines the basis of the 14-day rule in treating ruptured globes to prevent sympathetic ophthalmia. A key takeaway is understanding the importance of whole-of-person care when considering treatment options. View article here Freny Kalapesi is…
…
continue reading
1
S02E01 Can weight loss cure eye disease? Effectiveness of Bariatric Surgery vs Community Weight Management Intervention for the Treatment of Idiopathic Intracranial Hypertension
12:35
Can weight loss cure eye disease? Effectiveness of Bariatric Surgery vs Community Weight Management Intervention for the Treatment of Idiopathic Intracranial Hypertension. Can weight loss cure eye disease? In the case of Idiopathic Intracranial Hypertension (IIH), yes! A/Prof Clare Fraser talks us through the much-awaited follow-up article examinin…
…
continue reading
1
S01E11 Factors Affecting Corneal Incision Position During Femtosecond Laser-assisted Cataract Surgery
13:08
Factors Affecting Corneal Incision Position During Femtosecond Laser-assisted Cataract Surgery Dr Kerrie Meades was the first female ophthalmologist to perform laser vision correct in Australia. In this podcast, Dr Meades discusses the article Factors affecting corneal incision position during femtosecond laser-assisted cataract surgery. Dr Meades …
…
continue reading
1
S01E10 Associations Between Anterior Segment Parameters and Rotational Stability of a Plate-haptic Toric Intraocular Lens
11:55
Associations Between Anterior Segment Parameters and Rotational Stability of a Plate-haptic Toric Intraocular Lens At face value – does the data always support the conclusion? Dr Madeleine Adams, a cataract surgeon and comprehensive ophthalmologist with a PhD from the University of Melbourne for her research into age-related macular degeneration, o…
…
continue reading
1
S01E09 Periocular Triamcinolone versus Intravitreal Triamcinolone versus Intravitreal Dexamethasone Implant for the Treatment of Uveitic Macular Edema: The PeriOcular versus INTravitreal Corticosteroids ...
11:17
Periocular Triamcinolone versus Intravitreal Triamcinolone versus Intravitreal Dexamethasone Implant for the Treatment of Uveitic Macular Edema: The PeriOcular versus INTravitreal Corticosteroids for Uveitic Macular Edema (POINT) Trial Dr Priya Samalia is a medical retina and uveitis fellow working at the Royal Victorian Eye and Ear Hospital. She e…
…
continue reading
1
S01E08 The Pneumatic Retinopexy versus Vitrectomy for the Management of Primary Rhegmatogenous Retinal Detachment Outcomes Randomized Trial (PIVOT)
9:45
The Pneumatic Retinopexy versus Vitrectomy for the Management of Primary Rhegmatogenous Retinal Detachment Outcomes Randomized Trial (PIVOT) Dr Mali Okada is a consultant at the RVEEH and senior researcher at CERA. In this podcast she discusses the various management options of retinal detachment. Pneumatic retinopexy is routinely used as the first…
…
continue reading
Laser-assisted in Situ Keratomileusis Long Term Outcomes in Late Adolescence Challenging the norms and parameters of safe LASIK surgery in late adolescents with Dr Tanya Trinh, cornea and refractive surgeon and staff specialist at Sydney Eye Hospital. Myopic disease burden is significant, increasing and contributes to serious comorbidities with pro…
…
continue reading
Accuracy of Intraocular Lens Power Formulas Modified for Patients with Keratoconus Which IOL formula should we use prior to cataract surgery in patients with keratoconus? Are the newer formulae with keratoconus modifications more accurate than the regular formulae that we are used to using? What should be our refractive target for these cases and h…
…
continue reading
1
S01E05 Clinical Results of Topography-based Customized Ablations in Highly Aberrated Eyes and Keratoconus/ectasia with Cross-linking
13:29
Clinical Results of Topography-based Customized Ablations in Highly Aberrated Eyes and Keratoconus/Ectasia with Cross-linking On the laser’s edge – breaking taboos! Dr Aanchal Gupta is the Director of Training for the South Australian Training network and a Senior Clinical lecturer at the University of Adelaide. She reviews Clinical results of topo…
…
continue reading
1
S01E04 Eplerenone for Chronic Central Serous Chorioretinopathy in Patients with Active, Previously Untreated Disease for more than 4 Months (VICI)
11:50
Eplerenone for Chronic Central Serous Chorioretinopathy in Patients with Active, Previously Untreated Disease for more than 4 Months (VICI): A Randomised, Double-blind, Placebo-controlled Trial The VICI trial is highly topical. Dr Narme Deva, Consultant Ophthalmologist & Honorary Senior Lecturer at the University of Auckland, explores the Eplerenon…
…
continue reading
Selective Laser Trabeculoplasty: A Review Published in RANZCO’s own Clinical and Experimental Ophthalmology Selective laser trabeculoplasty (SLT) has become an essential part of glaucoma management. In this 10 Minutes of Science, Dr Alina Zeldovich explores Selective laser trabeculoplasty: A review published in RANZCO’s own Clinical and Experimenta…
…
continue reading
1
S01E02 Intravitreous Anti-VEGF vs. Prompt Vitrectomy for Vitreous Hemorrhage from Proliferative Diabetic Retinopathy (Protocol AB)
8:46
Intravitreous Anti-VEGF vs. Prompt Vitrectomy for Vitreous Hemorrhage from Proliferative Diabetic Retinopathy (Protocol AB) Dr Cheryl Au, current medical retinal fellow at Westmead Hospital, explores Intravitreous Anti-VEGF vs. Prompt Vitrectomy for Vitreous Hemorrhage from Proliferative Diabetic Retinopathy. She was prompted to review the article …
…
continue reading
Is Rituximab a Wonder-drug? Dr Diana Conrad, Director of the Uveitis Service at the Royal Women’s and Children’s Hospital (the only speciality uveitis service in Queensland) explores a review paper on the use of rituximab for the treatment of non-infectious uveitis and scleritis. Dr Conrad notes an impressive response rate to rituximab for patients…
…
continue reading
